BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 6673503)

  • 1. Nitroblue tetrazolium slide test. Use of the phorbol-myristate-acetate-stimulated NBT-reduction slide test for routine and prenatal detection of chronic granulomatous disease and diagnosis of heterozygous carriers.
    Johansen KS
    Acta Pathol Microbiol Immunol Scand C; 1983 Dec; 91(6):349-54. PubMed ID: 6673503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phorbol myristate acetate stimulated NBT test: a simple method suitable for antenatal diagnosis of chronic granulomatous disease.
    Levinsky RJ; Harvey BA; Rodeck CH; Soothill JF
    Clin Exp Immunol; 1983 Nov; 54(2):595-8. PubMed ID: 6360441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carrier screening and prenatal detection of chronic granulomatous disease in Iran.
    Ayatollahi M; Geramizadeh B
    Saudi Med J; 2006 Sep; 27(9):1334-7. PubMed ID: 16951769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A fast and easy nitroblue tetrazolium method for carrier screening and prenatal detection of chronic granulomatous disease.
    Ayatollahi M; Tabei Z; Ramzi M; Kashef S; Haghshenas M
    Arch Iran Med; 2006 Oct; 9(4):335-8. PubMed ID: 17061605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal diagnosis of chronic granulomatous disease.
    Matthay KK; Golbus MS; Wara DW; Mentzer WC
    Am J Med Genet; 1984 Apr; 17(4):731-9. PubMed ID: 6720741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Staining of eosinophils with nitroblue tetrazolium in patients with chronic granulomatous disease.
    Roberts RL; Ohno Y; Gallin JI
    Pediatr Res; 1986 Apr; 20(4):378-80. PubMed ID: 2422626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophil function screening in patients with chronic granulomatous disease by a flow cytometric method.
    Epling CL; Stites DP; McHugh TM; Chong HO; Blackwood LL; Wara DW
    Cytometry; 1992; 13(6):615-20. PubMed ID: 1451593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Exclusion prenatal diagnosis of chronic familial septic granulomatosis].
    Pham Huu T; Dumez Y; Durand A; Le Merrer M; Lemerle-Gruson S; Hakim J; Griscelli C
    Arch Fr Pediatr; 1985 Feb; 42(2):103-5. PubMed ID: 4004464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An improved micromethod for evaluating the phagocytic potential of granulocytes by the nitroblue tetrazolium (NBT) slide test.
    Murphy KA; Kelleher JJ
    Am J Med Technol; 1982 Apr; 48(4):271-5. PubMed ID: 6178291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of flow cytometric methods for diagnosis of chronic granulomatous disease variants under routine laboratory conditions.
    Emmendörffer A; Nakamura M; Rothe G; Spiekermann K; Lohmann-Matthes ML; Roesler J
    Cytometry; 1994 Sep; 18(3):147-55. PubMed ID: 7813334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic granulomatous disease. Expression of the metabolic defect by in vitro culture of bone marrow progenitors.
    Newburger PE; Kruskall MS; Rappeport JM; Robinson SH; Chovaniec ME; Cohen HJ
    J Clin Invest; 1980 Sep; 66(3):599-602. PubMed ID: 6249853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prenatal diagnosis of chronic granulomatous disease (CGD) in four high risk male fetuses.
    Huu TP; Dumez Y; Marquetty C; Durandy A; Boue J; Hakim J
    Prenat Diagn; 1987 May; 7(4):253-60. PubMed ID: 3588543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of nitroblue tetrazolium (NBT) test.
    Parvaneh N; Teimourian S
    Arch Iran Med; 2008 Jan; 11(1):129-30; author reply 130. PubMed ID: 18389564
    [No Abstract]   [Full Text] [Related]  

  • 14. Flow cytometric evaluation of nitro blue tetrazolium (NBT) reduction in human polymorphonuclear leukocytes.
    Fattorossi A; Nisini R; Le Moli S; De Petrillo G; D'Amelio R
    Cytometry; 1990; 11(8):907-12. PubMed ID: 2272251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytochrome b deficiency in an autosomal form of chronic granulomatous disease. A third form of chronic granulomatous disease recognized by monocyte hybridization.
    Weening RS; Corbeel L; de Boer M; Lutter R; van Zwieten R; Hamers MN; Roos D
    J Clin Invest; 1985 Mar; 75(3):915-20. PubMed ID: 3980731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An improved nitroblue tetrazolium test using phorbol myristate acetate-coated coverslips.
    Repine JE; Rasmussen B; White JG
    Am J Clin Pathol; 1979 May; 71(5):582-5. PubMed ID: 453076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional evaluation of human neutrophils. Is the bactericidal activity correlated with nitroblue tetrazolium reduction?
    Bellinati-Pires R; Carneiro-Sampaio MM; Colletto GM
    J Investig Allergol Clin Immunol; 1992; 2(3):146-53. PubMed ID: 1342894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell damage and dye reduction in the quantitative nitroblue tetrazolium (NBT) test.
    Segal AW; Levi AJ
    Clin Exp Immunol; 1975 Feb; 19(2):309-18. PubMed ID: 1212802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of carriers of the autosomal form of chronic granulomatous disease.
    Verhoeven AJ; van Schaik ML; Roos D; Weening RS
    Blood; 1988 Feb; 71(2):505-7. PubMed ID: 3337910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitroblue tetrazolium test in patients with neoplasma during surgical treatment.
    Korenkiewicz A; Merkiel K; Prokopowicz J
    Neoplasma; 1983; 30(5):619-22. PubMed ID: 6656966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.